Interleukins Associated with Breast Cancer
Open Access
- 5 November 2018
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 10 (11) , e3549
Abstract
A tumor consists of a group of cells with abnormal growth, capable of acquiring unique characteristics that provide them with the ability to display mercurial migration patterns, adapting to microenvironments and their chemical and physical factors. Interleukins are small proteins secreted mainly by CD3+ and CD4+ T lymphocytes that mediate the "essential for cancer progression" interactions between cells. Interleukins are implicated in both the development and differentiation of different cells (NK, B, and T leukocytes) and, in general, play a major role in many diseases, including breast cancer, due to their unique participation in systemic inflammation and immune system modulation. During the past decade, interleukins proved to be decisive for future immunotherapy, predisposing a more reliable treatment with fewer side effects on normal proliferating cells. The aim of this review is to provide an overview of the role of interleukins implicated in breast cancer progression.Keywords
This publication has 46 references indexed in Scilit:
- Interleukin-2 Gene Polymorphisms and Prognosis of Breast CancerGenetic Testing and Molecular Biomarkers, 2013
- Interleukin‐17‐producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factorHistopathology, 2013
- Clinical significance of circulating interleukin‐23 as a prognostic factor in breast cancer patientsJournal of Cellular Biochemistry, 2012
- Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical OutcomeClinical Cancer Research, 2012
- Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdateBMC Cancer, 2010
- Overexpression of Interleukin-13 Receptor-α2 in Neuroendocrine Malignant Pheochromocytoma: A Novel Target for Receptor Directed Anti-Cancer TherapyThe Journal of Clinical Endocrinology & Metabolism, 2009
- IL‐1 family in breast cancer: Potential interplay with leptin and other adipocytokinesFEBS Letters, 2008
- Cytokine Comparisons Between Women With Breast Cancer and Women With a Negative Breast BiopsyNursing Research, 2008
- Interleukin 7 induces the growth of breast cancer cells through a wortmannin-sensitive pathwayBritish Journal of Surgery, 2004
- A Potential Role for Interleukin-8 in the Metastatic Phenotype of Breast Carcinoma CellsThe American Journal of Pathology, 2001